Your browser doesn't support javascript.
loading
The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations.
Collins, Dearbhaile C; Chenard-Poirier, Maxime; Lopez, Juanita S.
Affiliation
  • Collins DC; Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, SM2 5PT, London, United Kingdom.
  • Chenard-Poirier M; Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, SM2 5PT, London, United Kingdom.
  • Lopez JS; Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, SM2 5PT, London, United Kingdom.
Curr Cancer Drug Targets ; 18(4): 355-364, 2018.
Article in En | MEDLINE | ID: mdl-28969535
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Phosphatidylinositol 3-Kinase / Immunity, Cellular / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Cancer Drug Targets Journal subject: ANTINEOPLASICOS / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Phosphatidylinositol 3-Kinase / Immunity, Cellular / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Cancer Drug Targets Journal subject: ANTINEOPLASICOS / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication: